Company news

Integra LifeSciences Holdings Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer

November 3, 2024

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024

October 13, 2024

Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference

September 3, 2024

Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference

September 3, 2024

Integra LifeSciences Continues to Make Progress on Its ESG Strategy

August 20, 2024

Integra LifeSciences Reports Second Quarter 2024 Financial Results

July 28, 2024

Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts

July 14, 2024

Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024

July 14, 2024

Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference

May 12, 2024

Integra LifeSciences Reports First Quarter 2024 Financial Results

May 5, 2024

Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting

April 29, 2024

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024

April 17, 2024

Integra LifeSciences Completes the Acquisition of Acclarent, Inc.

March 31, 2024

Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases

March 10, 2024

Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

February 27, 2024

Integra LifeSciences Announces Leadership Transition Plan

February 27, 2024

Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

February 6, 2024

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 4, 2024

Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®

December 12, 2023

Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors

December 11, 2023

Integra LifeSciences Reports Third Quarter 2023 Financial Results

October 24, 2023

Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023

October 3, 2023

Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference

August 31, 2023

Integra LifeSciences Reports Second Quarter 2023 Financial Results

July 25, 2023

Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023

July 2, 2023

Integra LifeSciences Announces Complete Enrollment in DuraSorb® Monofilament Mesh U.S. IDE Study

June 27, 2023

Integra LifeSciences Appoints Lea Daniels Knight, Executive Vice President and Chief Financial Officer

June 20, 2023

Integra LifeSciences Opens New Center of Innovation and Learning

May 10, 2023

Integra LifeSciences To Host Investor Day On May 4, 2023

May 2, 2023

Integra LifeSciences Reports First Quarter 2023 Financial Results

April 25, 2023

Integra LifeSciences to Host First Quarter 2023 Financial Results Conference Call on April 26, 2023

April 2, 2023

Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance

February 21, 2023

Integra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023

February 8, 2023

Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials

January 9, 2023

Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates

December 5, 2022

Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase

November 30, 2022

Integra LifeSciences Reports Third Quarter 2022 Financial Results

October 25, 2022

Integra LifeSciences to Host Third Quarter 2022 Financial Results Conference Call on October 26, 2022

October 6, 2022

Integra LifeSciences Announces Key Executive Appointment

October 5, 2022

Integra LifeSciences Publishes Its Inaugural ESG Report

September 28, 2022

Integra LifeSciences Announces Participation in Upcoming Investor Conferences

August 22, 2022

Integra LifeSciences Announces the Passing of Dr. Richard Caruso, Founder and Former Chairman and CEO

August 15, 2022

Integra LifeSciences Reports Second Quarter 2022 Financial Results

July 26, 2022

Integra LifeSciences Appoints Renee Lo as Director

July 18, 2022

Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022

June 30, 2022

Integra LifeSciences Reports First Quarter 2022 Financial Results

April 26, 2022

Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022

March 31, 2022

Integra LifeSciences Launches NeuraGen® 3D Nerve Guide Matrix

March 21, 2022

Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance

February 22, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 40 decks. Every deck is listed under its year.